Browsing by Author "GERMAIN, A"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemBLEEDING-TIME IN PREECLAMPSIA(MUNKSGAARD INT PUBL LTD, 1994) IVANKOVIC, M; PEREIRA, J; BIANCHI, M; GERMAIN, A; MEZZANO, DThe association of preeclampsia with thrombocytopenia and prolonged bleeding time is reported. The analysis of bleeding time (Simplate II) and the platelet count (Automatic Coulter Counter) in 41 patients with different grades of preeclampsia is presented. Our results suggest that the decrease in the bleeding time observed in moderate preeclampsia and the increase observed in severe preeclampsia are not mainly dependent on the platelet count.
- ItemEFFECT OF MATERNAL ADMINISTRATION OF THYROTROPIN-RELEASING-HORMONE ON THE PRETERM FETAL PITUITARY-THYROID AXIS(1991) MAYA, F; MENA, P; FORADORI, A; BECERRA, M; INZUNZA, A; GERMAIN, AWe evaluated the response of preterm fetuses to maternal intravenous injection of 400-mu-g of thyrotropin releasing hormone (TRH) between 30 minutes and 5 hours before delivery (n = 12). An additional seven mothers received saline solution and served as control subjects. There were no statistically significant differences in gestational age, birth weight, or Apgar scores between groups. At delivery, concentrations of maternal thyrotropin were elevated in the TRH group compared with the control group (12.0 +/- 1.6 vs 5.6 +/- 0.5 mU/L; p < 0.005); however, maternal triiodothyronine (T3) values remained unchanged. Significant elevations of fetal thyrotropin and T3 were observed after maternal administration of TRH compared with control subjects (45.8 +/- 7.7 vs 8.4 +/- 0.9 mU/L (p < 0.002) and 1.3 +/- 0.07 vs 0.7 +/- 0.04 nmol/L or 87 +/- 5 vs 49 +/- 3 ng/dl (p < 0.001), respectively). Fetal thyroxine (T4) and prolactin values were also elevated after exposure to TRH (135 +/- 5 vs 86 +/- 10 nmol/L or 10.5 +/- 0.4 vs 6.7 +/- 0.8-mu-g/dl (p < 0.001) and 212 +/- 31 vs 105 +/- 28-mu-g/L (p < 0.05), respectively). Two hours after birth, a significant increase in T3 but not T4 levels was observed in both groups of infants. These data indicate that fetal exposure to a single dose of TRH via maternal administration of this hormone results in marked stimulation of the preterm fetal pituitary-thyroid axis, as in the fetus at term, and that this treatment does not inhibit the early postnatal surge of T3.